Covered recipient · General Payments record
EMMANUEL N MOUSTAKAKIS
Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology
General Payments · PY2018–2024
$7,609.12
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $409.70 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $249.87 | 12 |
| Amgen Inc. | $137.73 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $102.52 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117635265 | CMS |
| Amgen Inc. | $4.37 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656888 | CMS |
| Amgen Inc. | $20.34 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117635267 | CMS |
| Amgen Inc. | $10.50 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656890 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.10 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118017076 | CMS |
| Medtronic, Inc. | $8.33 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326945 | CMS |
| Medtronic, Inc. | $4.71 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326953 | CMS |
| Medtronic, Inc. | $38.98 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326951 | CMS |
| Medtronic, Inc. | $9.43 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326947 | CMS |
| Medtronic, Inc. | $9.93 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326949 | CMS |
| Medtronic, Inc. | $10.32 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326955 | CMS |
| Medtronic, Inc. | $8.82 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326957 | CMS |
| Medtronic, Inc. | $12.36 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326959 | CMS |
| Medtronic, Inc. | $14.06 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326961 | CMS |
| Medtronic, Inc. | $12.23 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326963 | CMS |
| Medtronic, Inc. | $110.00 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326965 | CMS |
| Medtronic, Inc. | $10.70 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119326967 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.